Genocea Biosciences (NASDAQ:GNCA) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research report released on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a debt-to-equity ratio of 0.24, a current ratio of 1.35 and a quick ratio of 1.35. The […]

Leave a Reply

Your email address will not be published.

Previous post Dynatronics (NASDAQ:DYNT) Earns Hold Rating from Analysts at StockNews.com
Next post StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM)